Nutrition
Volume 26, Issue 1 , Pages 112-119 , January 2010

Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism

  • Tao Huang, B.Sc.

      Affiliations

    • Department of Food Science and Nutrition, Zhejiang University, Hangzhou, China
    • APCNS Centre of Nutrition and Food Safety, Hangzhou, China
    • ,
  • Mark L. Wahlqvist, Ph.D.

      Affiliations

    • Department of Food Science and Nutrition, Zhejiang University, Hangzhou, China
    • APCNS Centre of Nutrition and Food Safety, Hangzhou, China
    • National Health Research Institutes, Zhunan, Taiwan
    • ,
  • Duo Li, Ph.D.

      Affiliations

    • Department of Food Science and Nutrition, Zhejiang University, Hangzhou, China
    • APCNS Centre of Nutrition and Food Safety, Hangzhou, China
    • Corresponding Author InformationCorresponding author: Tel./fax: +86-571-8697-1024.

Received 13 June 2008 ,Accepted 18 May 2009.

References 

  1. Arnesen E, Refsum H, Bonna KH, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995;24:704–709
  2. McCully KS. Vascular pathology of homocysteinemia implication for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–128
  3. Huang T, Yuan GF, Zhang ZG, Zou ZQ, Li D. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pac J Clin Nutr. 2008;17:8–16
  4. Kaul S, Zadeh AA, Shah PK. Homocysteine hypothesis for atherothrombotic cardiovascular disease, not validated. J Am Coll Cardiol. 2006;48:914–923
  5. Dinleyici EC, Kirel B, Alatas O, Muslumanoglu H, Kilic Z, Dogruel N. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors. J Trop Pediatr. 2006;52:260–266
  6. Sofi F, Marcucci R, Bolli P, Giambene B, Sodi A, Fedi S, et al. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis. 2008;198:223–227
  7. Gao S, Tang CS. The cellular molecular mechanism of hyperhomocysteine in atherosclerosis. Dev Physiol. 2002;33:335–338
  8. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217–246
  9. Hamelet J, Demuth K, Paul JL, Delabar JM, Janel N. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J Hepatol. 2007;46:151–159
  10. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31–62
  11. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Wolk A, Colditz GA, et al. Dietary Intake of α-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr. 1999;69:890–897
  12. Iso H, Rexrode KM, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001;285:304–312
  13. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)–Prevenzione. Circulation. 2002;105:1897–1903
  14. Erkkila AT, Lichtenstein AH, Mozaffarian D, Herrington DM. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr. 2004;80:626–632
  15. Morris MC, Sack F, RosnerDoes fish oil lower blood pressure? B. A meta-analysis of controlled trials. Circulation. 1993;88:523–533
  16. Svaneborg N, Moller JM, Schmidt EB, Varming K, Lervang HH, Dyerberg J. The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Lipids. 1994;29:145–147
  17. Schacky CV, Siess W, Fischer S, Weber PC. A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro. J Lipid Res. 1985;26:457–464
  18. Christensen JH, Skou HA, Madsen T, Torring I, Schmidt EB. Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med. 2001;249:545–552
  19. Li D, Yu XM, Xie HB, Zhang Y, Wang Q, Zhou X, et al. Platelet phospholipids n-3 PUFA negatively associated with plasma homocysteine in middle aged and geriatric hyperlipaemia patients. Prostaglandins Leukot Essent Fatty Acids. 2007;76:293–297
  20. Li D, Mann NJ, Sinclair AJ. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids. 2006;41:85–89
  21. Zeman M, Žák A, Vecka M, Tvrzická E, Písaříková A, Staňková B. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J Nutr Biochem. 2006;17:379–384
  22. Grundt H, Nilsen DW, Mansoor MA, Hetland O, Nordoy A. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb. 2003;33:88–95
  23. Michele TS, Richard AL, David H, Joaquin C, Rebecca MH, Sridevi D, et al. Hyperhomocysteinemia measured by immunoassay: a valid measure of coronary artery atherosclerosis. Arch Pathol Lab Med. 2004;128:1263–1266
  24. Pascal P, Elisabeth L, Michel V. Evaluation of the AxSYM homocysteine assay and comparison with the IMx homocysteine assay. Clin Chem. 2000;46:1440–1441
  25. Li D, Sinclair AJ, Mann N, Turner A, Ball M, Kelly F, et al. The effect of habitual diet on the thrombotic risk factors in healthy male subjects. Eur J Clin Nutr. 1999;53:612–619
  26. Cabrero C, Puerta J, Alemany S. Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. Eur J Biochem. 1987;170:299–304
  27. Hultberg B, Andersson A, Isaksson A. Copper ions differ from other thiol reactive metal ions in their effects on the concentration and redox status of thiols in Hela cell cultures. Toxicology. 1997;117:89–97
  28. Miller JW, Nadeau MR, Smith D, Selhub J. Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem J. 1994;298:415–419
  29. Geng B, Yang JH, Qi YF, Zhao J, Pang YZ, Du JB, et al. H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun. 2004;2:362–368
  30. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, et al. Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) study cohort I. Circulation. 2006;113:195–202
  31. Olszewski AJ, McCully KS. Fish oil decreases serum homocysteine in hyperlipemic men. Coron Artery Dis. 1993;4:53–60
  32. Grundt H, Nilsen DWT, Hetland A, Mansoor MA, Aarsland T, Woie L. Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thromb Haemost. 1999;81:561–566
  33. Nordstrom M, Kjellstrom T. Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease. Atherosclerosis. 1992;94:213–221
  34. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol. 1998;55:1449–1455
  35. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82:636–643
  36. Mudd SH, Finkelstein JD, Irreverre F, Laster L. Homocystinuria: an enzymatic defect. Science. 1964;143:1443–1445
  37. Köseoglua E, Karaman Y. Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Clin Biochem. 2007;40:859–863
  38. Afman LA, van der Put NMJ, Thomas CMG, Trijbels FJM, Blom HJ. Reduced vitamin B12 binding by transcobalamin II increased the risk of neural tube defects. Q J Med. 2001;94:159–166
  39. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:1103–1112
  40. Homocysteine Lowering Trialists Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. Br Med J. 1998;316:894–898
  41. Jacques PF, Sclhub J, Bostom AG, Wilson PWF, Rosenberg JH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999;340:49–54
  42. Reguera RM, Redondo CM, Pérez-Pertejo Y, Balaña-Fouce R. S-adenosylmethionine in protozoan parasites: functions, synthesis and regulation. Mol Biochem Parasitol. 2007;152:1–10
  43. Hamre MR, Clark SH, Mirkin BL. Resistance to inhibitors of S-adenosyl-L-homocysteine hydrolase in C1300 murine neuroblastoma tumor cells is associated with increased methionine adenosyltransferase activity. Oncol Res. 1995;7:487–492
  44. Dwivedi RS, Wang LJ, Mirkin BL. S-adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: a novel mechanism of drug resistance. Cancer Res. 1999;59:1852–1856
  45. Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost. 2000;26:219–225
  46. Finkelstein JD, Martin JJ. Methionine metabolism in mammals: distribution of homocysteine between competing pathways. J Biol Chem. 1984;259:9508–9513
  47. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr. 2002;132:2361S–2366S
  48. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr. 1998;157:S40–S44
  49. Diwakar L, Ravindranath V. Inhibition of cystathionine-γ-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int. 2007;50:418–426
  50. Green PS, Mendez AJ, Jacob JS, Growdon W, Hyman BT, Heinecke JW. Neuronal expression of myeloperoxidase isincreased in Alzheimer's disease. J Neurochem. 2004;90:724–733
  51. Chen L, Ingrid S, Ding YG, Liu Y, Qi JG, Tang CS, et al. Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J. 2007;120:389–393
  52. Wang YF, Shi L, Du JB, Tang CS. Impact of L-arginine on hydrogen sulfide/cystathionine-γ-lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem Biophy Res Commun. 2006;345:851–857

PII: S0899-9007(09)00236-6

doi: 10.1016/j.nut.2009.05.015

Nutrition
Volume 26, Issue 1 , Pages 112-119 , January 2010

Article Tools

* Image Usage & Resolution